JMHLY yields 3.17% · JNJ yields 2.13%● Live data
📍 JMHLY pulled ahead of the other in Year 1
Combined, JMHLY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JMHLY + JNJ for your $10,000?
Jardine Matheson Holdings Limited, through its subsidiaries, engages in the motor vehicles and related operations, property investment and development, food retailing, health and beauty, home furnishings, engineering and construction, and transportation businesses. It is also involved in the restaurants and hotels, financial services, heavy equipment, mining, and agribusinesses. The company offers airport ground handling, and aviation and transport services; and engineering, sourcing, and contracting services, as well as owns and operates air cargo terminals, and invests in residential properties. It is also involved in the Pizza Hut and KFC franchise restaurants operations; designing, engineering, installation, maintenance, and modernization of escalators, and moving walkways; and supplying aseptic packaging materials. In addition, the company provides automobile and motorcycle products, as well as sells and services motor vehicles; invests in, owns, develops, and manages office and retail properties; operates outlets, including supermarkets, hypermarkets, convenience stores, health and beauty stores, and home furnishings stores; and invests in and manages a portfolio of deluxe and first class hotels, resorts, and residences. Further, it engages in the motor dealerships, dairy, and cement businesses. Additionally, the company is involved in the energy, infrastructure, logistics, insurance brokerage, and information technology businesses. It operates in China, Southeast Asia, the United Kingdom, and internationally. The company was founded in 1832 and is based in Hamilton, Bermuda.
Full JMHLY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.